Attana

Attana
About Us
Quotes
Change country

Follow us:
Share:
Subscribe:

About Us

Attana was founded in 2002 with the vision of in vitro characterization of molecular interactions mimicking in vivo conditions. Since then, Attana has developed proprietary label free biosensors for biochemical, crude, sera, and cell-based assays and the Attana Virus Analytics (AVA) platform, a proprietary in vitro diagnostics (IVD) tool. Attana products and research services are used by Big Pharma, biotech companies and academic institutions within the life sciences. To learn more about our latest services and products, please visit www.attana.com or contact sales@attana.com

Quotes

This order is of strategic importance for Attana, since we are now involved at an early stage in designing R&D projects for a major drug development project. The order shows a market acceptance for our technology and capability to characterize interactions with cells, tissues, viruses etc it also provides a value of our application knowledge and the advises we can provide.

International Sales Manager Thomas Ljungberg

Pick a time period -

Tags ( Active)

All Regulatory Non-Regulatory

Attana has submitted an international patent application (PCT)

Tue, Feb 14, 2023 07:58 CET

Attana has filed an international patent application with claims for methods for assessing the neutralizing potential of antibodies in biological samples. The application claims priority from the national application filed February 18 th , 2022 and designates all PCT contracting states. The invention is applicable in both of

Information about Attana's presentation at Småbolagsdagarna on June 14 at 20.00

Fri, Jun 10, 2022 10:51 CET

On Tuesday, June 14 at 20.00 Attana will participate in Aktiespararnas event, Småbolagsdagarna, where Attana’s CEO, Teodor Aastrup, will present the company and answer questions from shareholders.The presentation will include a brief description of the company and its two business areas, Attana Life Science and Attana Diagnostics and focus on both the short- and long-term plans going forward. Preliminary agenda for the presentation 1. Attana in short 2. 20 years of intelligent bioanalysis 3. Life Science 4. Diagnostics 5. Attana 2030 The event will be open for all and no

There are no items matching the current filter

There are no more items matching the current filter

Share

About Us

Links

Quotes

Attana has submitted an international patent application (PCT)

Information about Attana's presentation at Småbolagsdagarna on June 14 at 20.00

Subscribe